Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Revenue
0
0
0
0
0
Selling, general and administrative
3
2
3
2
2
Research and development
0
1
0
1
1
Total operating expense
4
2
3
3
3
Loss from operations
-4
-2
-3
-3
-3
Interest income
0
0
0
0
0
Interest expense
0
0
0
0
0
Accretion of debt discount
0
0
-1
-1
-5
Loss on disposal of fixed assets
0
0
0
0
0
Gain on dissolution of foreign subsidiary
0
0
0
0
0
Foreign exchange loss
0
0
0
0
0
Change in fair value of warrant liability
0
0
0
0
0
Payable written off
0
0
0
0
0
Total other income (expense)
0
0
-1
-1
-5
Loss from continuing operations
-4
-2
0
0
0
Loss from discontinued operations
0
0
0
0
0
Net loss
-4
-2
-4
-4
-8
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 27, 2013 n/a
calculated values,
restated on Nov 14, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (25 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
2
1
0
1
0
Deferred research and development costs
0
0
0
0
0
Deferred offering costs
0
0
0
0
0
Prepaid expenses and other current assets
0
0
0
0
0
Total current assets
3
1
1
1
0
Equipment, net of accumulated depreciation of $4,346 and $463 at May 31, 2012 and August 31, 2011
0
0
0
0
0
Total assets
3
1
1
1
0
Liabilities and owners' equity
Accounts payable
0 119868
0 63403
0 122356
0 144239
0 97438
Interest payable to related party
0 161009
0 26231
0 0
0 193151
0 443498
Bridge note, net of discount of $6,516
0 0
0 0
0 0
0 0
1 593484
Convertible promissory note, net of $999,985 discount
0 0
0 515
0 0
1 686320
2 2120192
Derivative liability
0 0
0 0
0 0
0 0
0 0
Total current liabilities
0 280877
0 90149
0 122356
1 1023710
3 3254612
Convertible promissory notes payable to related party, net of discount of $1,961,847
0 0
0 0
0 0
0 0
0 0
Interest payable to related party
0 0
0 0
0 0
0 0
0 0
Total liabilities
0 0
0 0
0 0
0 0
3 3254612
Commitments and contingencies
0 0
0 0
0 0
0 0
0 0
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding at May 31, 2012 or August 31, 2011.
0 0
0 0
0 0
0 0
0 0
Common stock: $0.001 par value; 300,000,000 shares authorized, 20,638,360 shares issued and outstanding at May 31, 2012 and August 31, 2011.
0 20638
0 20638
0 24194
0 24306
0 26572
Additional paid-in capital
13 12593184
14 13798282
17 17441034
21 20872345
26 26144117
Retained deficit
-10 -10347926
-13 -12781357
-17 -17053889
-21 -20946270
-29 -29039014
Total stockholders' equity (deficit)
2 2265896
1 1037563
0 411339
0 -49619
-3 -2868325
Total liabilities and stockholders' equity (deficit)
3 2546773
1 1127712
1 533695
1 974091
0 386287
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Jul 12, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (29 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net loss
0
0
-4
-4
-8
Loss from continuing operations
-4
-2
0
0
0
Loss from discontinued operations
0
0
0
0
0
Depreciation
0
0
0
0
0
Stock based compensation
3
0
0
1
1
Accretion of debt discount
0
0
1
1
5
Warrants issued to note holder
0
0
1
0
0
Change in fair value of warrant liability
0
0
0
0
0
Loss on disposal of fixed assets
0
0
0
0
0
Payable written off
0
0
0
0
0
Common stock issued for services
0
0
0
0
0
Common stock issued for debt settlement
0
0
0
0
0
Reversal of stock based compensation expense due to forfeiture of stock options
-1
0
0
0
0
Decrease (increase) in deferred research and development costs
0
0
0
0
0
Decrease (increase) in prepaid expenses and other current assets
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
Increase (decrease) in related party payable
0
0
0
0
0
Increase (Decrease) In Accrued Liabilities
0
0
0
0
0
Net cash used in operating activities
-2
-2
-2
-3
-3
Purchase of equipment
0
0
0
0
0
Net cash used in investing activity
0
0
0
0
0
Repayment of promissory note
0
0
0
0
0
Proceeds from the exercise of warrants
4
0
1
0
1
Proceeds from promissory notes
0
1
0
3
1
Dividend paid
0
0
0
0
0
Net cash provided by financing activities
4
1
1
3
2
Increase (decrease) in cash and cash equivalents
2
-1
-1
0
-1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 27, 2013 n/a
calculated values,
restated on Nov 14, 2014 n/a
calculated values,
restated on Dec 11, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,